Cambridge, UK — Horizon Discovery Group plc (LSE:HZD) (Horizon), a leading provider of research tools to support translational genomics and the development of personalized medicines, today announced it has entered a worldwide co-exclusive distribution agreement with Haplogen Genomics GmbH (Haplogen). The agreement provides Horizon with access to a new high-throughput, affordable cell line engineering service. […]
BOULDER, CO –- ViroCyt, LLC, the leader in rapid virus quantification, announced today that, in partnership with I&L Biosystems GmbH, it is formally launching the Virus Counter® 3100 in Europe at the World Vaccine Congress to be held October 13-15 in Brussels, Belgium. “The Virus Counter 3100 is the marquee analytical tool for quickly quantifying […]
HERCULES, CA — Bio-Rad Laboratories, Inc. (NYSE: BIO) and (NYSE: BIO.B), a global provider of life science research and clinical diagnostics products, today announced the recent appointment of Mr. John Goetz as Chief Operating Officer. In his new role Mr. Goetz is responsible for all operating functions of the company on a global basis, including […]
CAMBRIDGE, Mass. — Stemgent Inc. announced today that it has completed the sale of its stem cell reagents and services business to ReproCELL in a cash transaction for approximately $8.5 million. Stemgent is selling the stem cell reagent and services business in order to focus on expanding its human tissue-based brand, Asterand Biosciences. Asterand has […]
Windsor, CT — Rainbow Scientific, Inc. (RSI), a North American distributor of scientific research products, recently opened an online store to add customer convenience in ordering its comprehensive cell culture product lines developed and manufactured by Biological Industries, Inc. Products available through its online store include Biological Industries’ Nutristem® serum-free, xeno-free reagents for human mesenchymal […]
San Diego, CA — ACEA Biosciences, Inc. (ACEA) has awarded Jonathan Chen at Yale University the 2014 iCELLigence Research Grant for his proposal on cancer cell drug resistance studies. ACEA’s iCELLigence instrument is an impedance based real-time label-free cellular analysis instrument. Jonathan Chen, a Ph.D. candidate in Department of Biomedical Engineering at Yale University currently […]
Hercules, CA — — Bio-Rad Laboratories, Inc. (NYSE BIO and BIOb) today announced the launch of the ZOE™ Fluorescent Cell Imager, one of the first cell imaging systems able to deliver the power of microscopy in a system that is as easy to use as a tablet. The system includes three fluorescent channels and brightfield […]
SOUTH SAN FRANCISCO, Calif.– Researchers at Stanford University have demonstrated the ability to predict the recovery time of patients who underwent surgical trauma. Convalescence after surgery varies significantly from patient to patient—often with protracted recovery periods resulting in personal suffering as well as substantial societal and economic costs. Now, using the deep profiling capabilities of […]
STEMCELL Technologies has received $949,500 in repayable assistance from the Western Innovation (WINN) Initiative for an exciting project to develop tools and assays for three-dimensional (3D) cell culture. Led by Dr. Steven Woodside, Director of Particle Chemistry and Engineering, and Dr. Eric Jervis, Principal Scientist, the project builds on STEMCELL Technologies’ extensive experience in developing […]
North Brunswick, NJ, USA — Hurel Corporation (“Hurel”), a world-leading provider of in vitro liver models and microfluidic assay platforms that improve the predictive reliability of pre-clinical drug development, today announced that Johnston Associates, Inc. of Princeton, New Jersey (“JAI”) has become a participating investor in the Company’s Series A-3 Preferred Stock financing. Hurel’s lead […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
